Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Alcon Inc. Ordinary Shares (ALC)

Alcon Inc. Ordinary Shares (ALC) is trading at $80.20, with recent price declines attributed to a revised 2025 outlook and analyst downgrades. However, the company has also announced an amended merger agreement to acquire Staar Surgical for $XXXXX per share, a move that has generated mixed reactions.

### About Alcon Inc. Ordinary Shares
Alcon Inc. Ordinary Shares (ALC) is a stock in the Healthcare sector, focusing on eye care products and services.  
Alcon Inc. Ordinary Shares uses the ticker $ALC for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alcon Inc. Ordinary Shares (ALC) engagements hit 12.9K which is XXX% higher than it's daily average.
- Alcon Inc. Ordinary Shares (ALC) trading volume is up XXXXX% from the previous week.
- Alcon Inc. Ordinary Shares (ALC) social dominance is up XXXXXX% from the previous week.
- Alcon Inc. Ordinary Shares (ALC) Galaxy Score™ is up XXXXXX% from the previous week.
- Alcon Inc. Ordinary Shares (ALC) sentiment is up XXXXXX% from the previous week.
- Alcon Inc. Ordinary Shares (ALC) engagements is up XXXXX% from the previous month.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$alc/time-series/close.tsv)  
The current price decline is attributed to negative sentiment stemming from a revised 2025 outlook and analyst downgrades, compounded by opposition to the Staar Surgical acquisition. This is overshadowing positive news like FDA approval and a dividend increase.  

24-Hour: XXXX%
7-Day: XXXX%
30-Day: XXXX%

1-Year High: $XXXXX on 2025-05-02  
1-Year Low: $XXXXX on 2025-10-10  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$alc/time-series/alt_rank.tsv)  
Alcon Inc. Ordinary Shares (ALC) is currently AltRank #663 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX -XXX  
X Month: XXXXX +455  
X Months: XXXXX -XXX  
X Year: XXXXX +22  
1-Year High: XXXXX on 2025-09-23  
1-Year Low: XX on 2024-12-29  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alc/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +37  
X Month: XX no change  
X Months: XX +11  
X Year: XX +9  
1-Year High: XX on 2025-03-27  
1-Year Low: XX on 2025-10-28  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$alc/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXXX +61%  
X Month: XXXXXXX +73%  
X Months: XXXXXXXXX +45%  
X Year: XXXXXXXXX +35%  
1-Year High: XXXXXXX on 2025-08-20  
1-Year Low: XXX on 2025-12-07  

Engagements by network (24h):
TikTok: XX
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$alc/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +48%  
X Months: XXXXX +22%  
X Year: XXXXX +77%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-12-06  

Mentions by network (24h):
TikTok: XX
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$alc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Alcon Inc. Ordinary Shares (ALC) in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +73%  
X Months: XXXXX +75%  
X Year: XXXXX +180%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-12-06  

The most influential creators that mention Alcon Inc. Ordinary Shares in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXX       |
| [@diane_alter](/creator/twitter/diane_alter)         | X    | XXXXX     | X     | XXX         |
| [@richtrades100](/creator/twitter/richtrades100)     | X    | XXXXX     | X     | XXX         |
| [@ArbStocktipster](/creator/twitter/ArbStocktipster) | X    | XXXXX     | X     | XX          |
| [@cashInsider](/creator/twitter/cashInsider)         | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$alc/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$alc/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +50%  
X Month: XX% +33%  
X Months: XX% no change  
X Year: XX% +13%  
1-Year High: XXX% on 2025-02-24  
1-Year Low: XX% on 2025-02-03  

Most Supportive Themes:
- Positive Analyst Sentiment: (25%) Analysts maintain positive ratings and price targets for Alcon Inc. Ordinary Shares.
- Dividend Increase: (20%) Alcon Inc. announced a notable increase in its dividend payout.
  
Most Critical Themes:
- Staar Surgical Acquisition Opposition: (10%) Concerns and opposition are being raised regarding Alcon's potential acquisition of Staar Surgical.
- Revised 2025 Outlook Concerns: (5%) There are concerns about Alcon's future performance based on a revised 2025 outlook.
- Analyst Downgrades: (3%) Alcon Inc. Ordinary Shares has seen recent downgrades from analysts.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$alc/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXX%  
X Week: XXXXXX% +0.0028%  
X Month: XXXXXX% -XXXXX%  
X Months: XXXXXX% -XXXXXX%  
X Year: XXXXXX% -XXXXX%  
1-Year High: XXXXX% on 2025-01-10  
1-Year Low: XXXXX% on 2025-12-06  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$alc/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXX% on 2025-04-09  
1-Year Low: XXXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$alc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$alc/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX -$0.33%  
X Month: $XXXXXXXXXXXXXX +$6.90%  
X Months: $XXXXXXXXXXXXXX -$8.40%  
X Year: $XXXXXXXXXXXXXX -$8%  
1-Year High: $XXXXXXXXXXXXXX on 2025-05-02  
1-Year Low: $XXXXXXXXXXXXXX on 2025-10-10  

### Top Alcon Inc. Ordinary Shares Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"📌 Biotech Stock News 12/10 @ Open $TERN XX% $650M Offering $DYN X% $350M Public Offering $BRNS X% VTP-1000 Trial Update $MDWD X% Clinical Data on NexoBrid's Effectiveness $GPCR X% Pricing of $650M Offering $SGMT X% Denifanstat NDA Accepted by China NMPA $PTCT X% Health Canada Approves Sephience $ALC X% Response to Increased Acquisition Price $LXRX X% ACSL5 Preclinical Data Publucation $PFE X% TUKYSA Extends Survival 8mths $LLY X% Build $6B facility in Alabama $KYMR X% $602M Offering $AMRX X% Epinephrine Injection FDA Approval $NCNA -X% NUC-7738 Latest Data $PRAX -X% Elsunersen Accelerated"  
[X Link](https://x.com/BiopharmIQ/status/1998792850193232042) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-10T16:32Z 28.1K followers, 1190 engagements


"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"  
[X Link](https://x.com/BiopharmIQ/status/1998789058378739986) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-10T16:17Z 28.1K followers, 2076 engagements


"STOCK MOVERS 🔹 $ALC buying $STAA for 30.75/share 🔹 $GOOGL facing new EU antitrust probe 🔹 $ARES joining the $SPX; $K leaving via Mars acquisition 🔹 $C warns Q4 markets revenue down low to mid single digits 🔹 $CVS raises FY25 EPS midpoint 🔹 $FMC downgraded at Barclays 🔹 $HD reaffirms outlook; FY25/26 light 🔹 $JPM reinforces weak Q4 revenue mix 🔹 $NVDA allowed to ship H200s but under tight controls; China limiting access 🔹 $PEP cutting costs after deal with Elliott 🔹 SpaceX (private) prepping for a massive 2026 IPO 🔹 $TOL profit light with soft FY guidance"  
[X Link](https://x.com/CHItraders/status/1998504339443204579) [@CHItraders](/creator/x/CHItraders) 2025-12-09T21:25Z 5108 followers, XXX engagements


"👁 STAAR Surgical $STAA jumped XX% pre-market after Alcon $ALC announced a revised merger agreement to acquire the company. Under the updated terms Alcon will buy all outstanding STAA shares for $XXXXX in cash valuing the deal at $1.6B. The transaction is expected to close in early 2026 with Alcon forecasting that the acquisition will be earnings-accretive by year two. Despite todays surge STAA was down XXX% YoY before the announcement. The deal strengthens Alcons ophthalmic device portfolio and provides shareholders with a sizeable premium 💼🔍 #Healthcare #Mergers #MedTech"  
[X Link](https://x.com/lwsresearch/status/1998392018519667158) [@lwsresearch](/creator/x/lwsresearch) 2025-12-09T13:59Z 5493 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Alcon Inc. Ordinary Shares (ALC)

Alcon Inc. Ordinary Shares (ALC) is trading at $80.20, with recent price declines attributed to a revised 2025 outlook and analyst downgrades. However, the company has also announced an amended merger agreement to acquire Staar Surgical for $XXXXX per share, a move that has generated mixed reactions.

About Alcon Inc. Ordinary Shares

Alcon Inc. Ordinary Shares (ALC) is a stock in the Healthcare sector, focusing on eye care products and services.
Alcon Inc. Ordinary Shares uses the ticker $ALC for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Alcon Inc. Ordinary Shares (ALC) engagements hit 12.9K which is XXX% higher than it's daily average.
  • Alcon Inc. Ordinary Shares (ALC) trading volume is up XXXXX% from the previous week.
  • Alcon Inc. Ordinary Shares (ALC) social dominance is up XXXXXX% from the previous week.
  • Alcon Inc. Ordinary Shares (ALC) Galaxy Score™ is up XXXXXX% from the previous week.
  • Alcon Inc. Ordinary Shares (ALC) sentiment is up XXXXXX% from the previous week.
  • Alcon Inc. Ordinary Shares (ALC) engagements is up XXXXX% from the previous month.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The current price decline is attributed to negative sentiment stemming from a revised 2025 outlook and analyst downgrades, compounded by opposition to the Staar Surgical acquisition. This is overshadowing positive news like FDA approval and a dividend increase.

24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXX%

1-Year High: $XXXXX on 2025-05-02
1-Year Low: $XXXXX on 2025-10-10

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Alcon Inc. Ordinary Shares (ALC) is currently AltRank #663 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX -XXX
X Month: XXXXX +455
X Months: XXXXX -XXX
X Year: XXXXX +22
1-Year High: XXXXX on 2025-09-23
1-Year Low: XX on 2024-12-29

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +37
X Month: XX no change
X Months: XX +11
X Year: XX +9
1-Year High: XX on 2025-03-27
1-Year Low: XX on 2025-10-28

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +61%
X Month: XXXXXXX +73%
X Months: XXXXXXXXX +45%
X Year: XXXXXXXXX +35%
1-Year High: XXXXXXX on 2025-08-20
1-Year Low: XXX on 2025-12-07

Engagements by network (24h): TikTok: XX X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +48%
X Months: XXXXX +22%
X Year: XXXXX +77%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-06

Mentions by network (24h): TikTok: XX X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Alcon Inc. Ordinary Shares (ALC) in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX +73%
X Months: XXXXX +75%
X Year: XXXXX +180%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-06

The most influential creators that mention Alcon Inc. Ordinary Shares in the last XX hours

Creator Rank Followers Posts Engagements
@BiopharmIQ X XXXXXX X XXXXX
@diane_alter X XXXXX X XXX
@richtrades100 X XXXXX X XXX
@ArbStocktipster X XXXXX X XX
@cashInsider X XXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +50%
X Month: XX% +33%
X Months: XX% no change
X Year: XX% +13%
1-Year High: XXX% on 2025-02-24
1-Year Low: XX% on 2025-02-03

Most Supportive Themes:

  • Positive Analyst Sentiment: (25%) Analysts maintain positive ratings and price targets for Alcon Inc. Ordinary Shares.
  • Dividend Increase: (20%) Alcon Inc. announced a notable increase in its dividend payout.

Most Critical Themes:

  • Staar Surgical Acquisition Opposition: (10%) Concerns and opposition are being raised regarding Alcon's potential acquisition of Staar Surgical.
  • Revised 2025 Outlook Concerns: (5%) There are concerns about Alcon's future performance based on a revised 2025 outlook.
  • Analyst Downgrades: (3%) Alcon Inc. Ordinary Shares has seen recent downgrades from analysts.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% +0.0028%
X Month: XXXXXX% -XXXXX%
X Months: XXXXXX% -XXXXXX%
X Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-10
1-Year Low: XXXXX% on 2025-12-06

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-04-09
1-Year Low: XXXXX% on 2025-12-10

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$0.33%
X Month: $XXXXXXXXXXXXXX +$6.90%
X Months: $XXXXXXXXXXXXXX -$8.40%
X Year: $XXXXXXXXXXXXXX -$8%
1-Year High: $XXXXXXXXXXXXXX on 2025-05-02
1-Year Low: $XXXXXXXXXXXXXX on 2025-10-10

Top Alcon Inc. Ordinary Shares Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"📌 Biotech Stock News 12/10 @ Open $TERN XX% $650M Offering $DYN X% $350M Public Offering $BRNS X% VTP-1000 Trial Update $MDWD X% Clinical Data on NexoBrid's Effectiveness $GPCR X% Pricing of $650M Offering $SGMT X% Denifanstat NDA Accepted by China NMPA $PTCT X% Health Canada Approves Sephience $ALC X% Response to Increased Acquisition Price $LXRX X% ACSL5 Preclinical Data Publucation $PFE X% TUKYSA Extends Survival 8mths $LLY X% Build $6B facility in Alabama $KYMR X% $602M Offering $AMRX X% Epinephrine Injection FDA Approval $NCNA -X% NUC-7738 Latest Data $PRAX -X% Elsunersen Accelerated"
X Link @BiopharmIQ 2025-12-10T16:32Z 28.1K followers, 1190 engagements

"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link @BiopharmIQ 2025-12-10T16:17Z 28.1K followers, 2076 engagements

"STOCK MOVERS 🔹 $ALC buying $STAA for 30.75/share 🔹 $GOOGL facing new EU antitrust probe 🔹 $ARES joining the $SPX; $K leaving via Mars acquisition 🔹 $C warns Q4 markets revenue down low to mid single digits 🔹 $CVS raises FY25 EPS midpoint 🔹 $FMC downgraded at Barclays 🔹 $HD reaffirms outlook; FY25/26 light 🔹 $JPM reinforces weak Q4 revenue mix 🔹 $NVDA allowed to ship H200s but under tight controls; China limiting access 🔹 $PEP cutting costs after deal with Elliott 🔹 SpaceX (private) prepping for a massive 2026 IPO 🔹 $TOL profit light with soft FY guidance"
X Link @CHItraders 2025-12-09T21:25Z 5108 followers, XXX engagements

"👁 STAAR Surgical $STAA jumped XX% pre-market after Alcon $ALC announced a revised merger agreement to acquire the company. Under the updated terms Alcon will buy all outstanding STAA shares for $XXXXX in cash valuing the deal at $1.6B. The transaction is expected to close in early 2026 with Alcon forecasting that the acquisition will be earnings-accretive by year two. Despite todays surge STAA was down XXX% YoY before the announcement. The deal strengthens Alcons ophthalmic device portfolio and provides shareholders with a sizeable premium 💼🔍 #Healthcare #Mergers #MedTech"
X Link @lwsresearch 2025-12-09T13:59Z 5493 followers, XXX engagements

Alcon Inc. Ordinary Shares (ALC)
/topic/$alc